NICE 'not minded' to recommend Biogen's Tecfidera without more info
This article was originally published in Scrip
Executive Summary
The National Institute for Health and Care Excellence (NICE) for England and Wales has said it is not minded to recommend Biogen Idec's oral multiple sclerosis drug Tecfidera (dimethyl fumarate) for use on the NHS, calling for more information before it makes a final decision.